EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS : vimars

/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2022. Highlights and Outlook Q4 sales grew...

Related Keywords

Japan , United States , Michaela Mussallem , Edwards Lifesciences , Prnewswire Edwards Lifesciences , Instagram , Product Group , Linkedin , Twitter , Drug Administration , Exchange Commission , Youtube , Facebook , Securities Exchange , Edwards Lifesciences Corporation , Program Discontinuation , Aortic Valve Replacement , Tricuspid Therapies , Structural Heart , Smart Recovery , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Consolidated Statements , Generally Accepted Accounting Principles , Property Litigation Expenses , Fair Value , Contingent Consideration Liabilities , Intangible Assets , Income Taxes , Months Ended December ,